ProcessIntermediate
How should bremelanotide (Vyleesi) be administered to premenopausal women?
Bremelanotide (Vyleesi) should be administered subcutaneously at a dose of 1.75 mg, at least 45 minutes before anticipated sexual activity. It is important not to exceed one dose in a 24-hour period and no more than eight doses in a month.
Key points
- Administer subcutaneously at 1.75 mg.
- Inject at least 45 minutes before sexual activity.
- Maximum of one dose per 24 hours.
- No more than eight doses per month.
Related questions
Mosbys 2021 Nursing Drug Reference by Linda Skidmore-Roth
Unknown
THIRTY-FOURTH EDITION · Elsevier Inc.